from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1376/-

LFCtreatmentdescriptionclass of inhibitor

0.133

Amikacinug/mL Amikacintranslation

-0.878

Cap5-10ug/mL Capreomycintranslation

-0.516

Rox10-50 ug/mL Roxithromycintranslation

-0.739

SM2-5 ug/mL Streptomycintranslation

-0.904

Tet5-10 ug/mL Tetracyclinetranslation

0.608

Rif0.2-5ug/mL Rifampicintranscription

-0.383

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.518

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.875

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.124

CPZ10-50 ug/mL Chlorpromazinerespiration

0.658

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.038

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.179

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.103

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.572

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.347

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.345

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.440

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.053

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.752

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.048

KCN5-20 ug/mL Potassium cyaniderespiration

3.499

NaN30.2-2 mM Sodium aziderespiration

0.491

Nigericin50 uM Nigericinrespiration

-0.600

TRC10-150 ug/mL Triclosanrespiration

0.331

TRZ10-25 ug/mL Thioridazinerespiration

2.442

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.152

menadione6-10 ug/mL Menadionerespiration

0.032

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-2.134

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.028

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.099

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.844

NRP_1Non-replicating persistence stage 1dosRassociated

-0.995

Amp0.2mg/mL AmpicillincellWall

-0.408

Cephalexin20-100 ug/mL CephalexincellWall

-0.571

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.046

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.275

EMB10-20 ug/mL EthambutolcellWall

-0.696

Eta12-40 ug/mL EthionamidecellWall

-1.108

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.770

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.132

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.475

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.034

BZA0.12 mg/mL BenzamidearomaticAmides

0.443

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.036

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.043

H2O24 mM hydrogen peroxideDNAdamaging

-0.342

Levo10 ug/mL LevofloxacinDNAdamaging

0.031

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.733

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.395

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.296

UVUV-irradiationDNAdamaging

-0.490

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.015

Antimycin12.5-50 ug/mL Antimycin A?

-0.217

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.163

PA_110-50 ug/mL Antitubercular compound PA-1?

0.016

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.685

PA8240.2-2 ug/mL PA-824?

-0.336

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.184

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.056

Verapamil50 uM Verapamil?

-0.089

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.018

methoxatin10-20 ug/mL Methoxatin?